Drug Patent List
Oppositions
Newsletter
Weekly Digest

Pharsight

Tigecycline Patent Expiration

Tigecycline was first introduced by Pf Prism Cv in its drug Tygacil on Jun 15, 2005. Another drug containing Tigecycline is Tigecycline. 9 different companies have introduced drugs containing Tigecycline.


Tigecycline Patents

Given below is the list of patents protecting Tigecycline, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Tigecycline US9855335 Tigecycline composition for injection Apr 07, 2033 Amneal
Tigecycline US9855355 Method and device for plasma-treating hollow bodies Apr 07, 2033 Amneal
Tygacil US10588975 Tigecycline compositions and methods of preparation Mar 13, 2026 Pf Prism Cv
Tygacil US7879828 Tigecycline compositions and methods of preparation Feb 05, 2029 Pf Prism Cv
Tygacil US8372995 Crystalline solid forms of tigecycline and methods of preparing same Oct 08, 2030 Pf Prism Cv
Tygacil US8975242 Tigecycline compositions and methods of preparation Oct 24, 2028 Pf Prism Cv
Tygacil US9254328 Tigecycline compositions and methods of preparation Mar 13, 2026 Pf Prism Cv
Tygacil US9694078 Tigecycline compositions and methods of preparation Mar 13, 2026 Pf Prism Cv
Tygacil USRE40086 Method for treating bacterial infection with novel 7-substituted-9-substituted amino 6-demethyl-6-deoxytetracyclines Jun 25, 2013

(Expired)

 Pf Prism Cv
Tygacil USRE40183 7-Substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines Apr 09, 2016

(Expired)

 Pf Prism Cv


A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Tigecycline's patents.

Given below is the list recent legal activities going on the following patents of Tigecycline.

Event Date Patent/Publication
Patent litigations
Payment of Maintenance Fee, 12th Year, Large Entity 11 Jul, 2024 US8372995(Litigated)
Payment of Maintenance Fee, 4th Year, Large Entity 10 Aug, 2023 US10588975
Payment of Maintenance Fee, 8th Year, Large Entity 13 Jul, 2023 US9254328
Payment of Maintenance Fee, 8th Year, Large Entity 10 Aug, 2022 US8975242(Litigated)
Payment of Maintenance Fee, 12th Year, Large Entity 13 Jul, 2022 US7879828(Litigated)
Expire Patent 07 Feb, 2022 US9855355
Maintenance Fee Reminder Mailed 23 Aug, 2021 US9855355
Payment of Maintenance Fee, 4th Yr, Small Entity 07 Jul, 2021 US9855335
Surcharge for late Payment, Small Entity 07 Jul, 2021 US9855335
Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 11 Jun, 2021 US9855335



Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳

Tigecycline Generics

Several generic applications have been filed for Tigecycline. The first generic version for Tigecycline was by Sandoz Inc and was approved on May 27, 2015. And the latest generic version is by Meitheal Pharmaceuticals Inc and was approved on May 13, 2021.

Given below is the list of companies who have filed for Tigecycline generic.


1. XELLIA PHARMS APS

Xellia Pharmaceuticals Aps has filed for 1 generic for Tigecycline. Given below are the details of the strengths of this generic introduced by Xellia Pharms Aps.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG/VIAL powder Discontinued INTRAVENOUS N/A Oct 18, 2019


2. SANDOZ

Sandoz Inc has filed for 1 generic for Tigecycline. Given below are the details of the strengths of this generic introduced by Sandoz.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG/VIAL powder Prescription INTRAVENOUS AP May 27, 2015


3. MEITHEAL

Meitheal Pharmaceuticals Inc has filed for 1 generic for Tigecycline. Given below are the details of the strengths of this generic introduced by Meitheal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG/VIAL powder Prescription INTRAVENOUS AP May 13, 2021


4. EUGIA PHARMA

Eugia Pharma Specialities Ltd has filed for 1 generic for Tigecycline. Given below are the details of the strengths of this generic introduced by Eugia Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG/VIAL powder Prescription INTRAVENOUS AP Jun 11, 2019


5. APOTEX

Apotex Inc has filed for 1 generic for Tigecycline. Given below are the details of the strengths of this generic introduced by Apotex.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG/VIAL powder Prescription INTRAVENOUS AP Dec 21, 2018